DNMT3A and urinary bladder carcinoma: By defining a functional signaling pathway, i.e., SNHG1/DNMT3A/miR-129-2-5p/Rac1, that drives stemness and invasion in advanced bladder cancer cells, our study should spur additional investigation into the value of therapeutically targeting components of this pathway.